Allergen immunotherapy for IgE‐mediated food allergy: a systematic review and meta‐analysis
Allergy2017Vol. 72(8), pp. 1133–1147
Citations Over TimeTop 1% of 2017 papers
Ulugbek Nurmatov, Sangeeta Dhami, Stefania Arasi, Giovanni Battista Pajno, Montserrat Fernández‐Rivas, Antonella Muraro, Graham Roberts, Cezmi A. Akdiş, Montserrat Álvaro‐Lozano, Kirsten Beyer, Carsten Bindslev‐Jensen, Wesley Burks, George Du Toit, Motohiro Ebisawa, Philippe Eigenmann, Edward F. Knol, Mika J. Mäkelä, Kari C. Nadeau, Liam O’Mahony, Nikolaos G. Papadopoulos, Lars K. Poulsen, Cansın Saçkesen, Hugh A. Sampson, Alexandra F. Santos, Ronald van Ree, Frans Timmermans, Aziz Sheikh
Abstract
AIT may be effective in raising the threshold of reactivity to a range of foods in children with IgE-mediated food allergy whilst receiving (i.e. desensitization) and post-discontinuation of AIT. It is, however, associated with a modest increased risk in serious systemic adverse reactions and a substantial increase in minor local adverse reactions. More data are needed in relation to adults, long term effects, the impact on QoL and the cost-effectiveness of AIT.
Related Papers
- → Oral Immunotherapy for Food Allergy(2017)102 cited
- → Oral Immunotherapy(2023)4 cited
- → Long-term follow-up of children who achieved sustained unresponsiveness after peanut oral immunotherapy(2023)6 cited
- → ORAL DESENSITIZATION TO PEANUT USING AR101 PEANUT ORAL IMMUNOTHERAPY IN A ROLL-OVER SAFETY STUDY ARC002(2018)4 cited
- → O055 Immunologic effects of AR101 during characterized oral desensitization immunotherapy (CODIT) for peanut allergy(2016)